OBJECTIVE: For antiretroviral therapy (ART) to have a population-level HIV prevention impact, high levels of HIV testing and effective linkages to HIV care among HIV-infected persons are required. METHODS: We piloted home-based counseling and testing (HBCT) with point-of-care CD4 count testing and follow-up visits to facilitate linkage of HIV-infected persons to local HIV clinics and uptake of ART in rural KwaZulu-Natal, South Africa. Lay counselor follow-up visits at months one, three and six evaluated the primary outcome of linkage to care. Plasma viral load was measured at baseline and month six. RESULTS: 671 adults were tested for HIV (91% coverage) and 201 (30%) were HIV-infected, of which 73 (36%) were new diagnoses. By month three, 90% of HIV-infected persons not on ART at baseline had visited an HIV clinic and 80% of those eligible for ART at baseline by South African guidelines (CD4≤200 cells/μL at the time of the study) had initiated ART. Among HIV-infected participants who were eligible for ART at baseline, mean viral load decreased by 3.23 log10 copies/mL (p<0.001) and the proportion with viral load suppression increased from 20% to 80% between baseline and month six. CONCLUSIONS: In this pilot of HBCT and linkages to care in KwaZulu-Natal, 91% of adults were tested for HIV. Linkage to care was ∼90% both among newly-identified HIV-infected persons as well as known HIVinfected persons who were not engaged in care. Among those eligible for ART, a high proportion initiated ART and achieved viral suppression, indicating high adherence and reduced infectiousness.
OBJECTIVE: For antiretroviral therapy (ART) to have a population-level HIV prevention impact, high levels of HIV testing and effective linkages to HIV care among HIV-infectedpersons are required. METHODS: We piloted home-based counseling and testing (HBCT) with point-of-care CD4 count testing and follow-up visits to facilitate linkage of HIV-infectedpersons to local HIV clinics and uptake of ART in rural KwaZulu-Natal, South Africa. Lay counselor follow-up visits at months one, three and six evaluated the primary outcome of linkage to care. Plasma viral load was measured at baseline and month six. RESULTS: 671 adults were tested for HIV (91% coverage) and 201 (30%) were HIV-infected, of which 73 (36%) were new diagnoses. By month three, 90% of HIV-infectedpersons not on ART at baseline had visited an HIV clinic and 80% of those eligible for ART at baseline by South African guidelines (CD4≤200 cells/μL at the time of the study) had initiated ART. Among HIV-infectedparticipants who were eligible for ART at baseline, mean viral load decreased by 3.23 log10 copies/mL (p<0.001) and the proportion with viral load suppression increased from 20% to 80% between baseline and month six. CONCLUSIONS: In this pilot of HBCT and linkages to care in KwaZulu-Natal, 91% of adults were tested for HIV. Linkage to care was ∼90% both among newly-identified HIV-infectedpersons as well as known HIVinfected persons who were not engaged in care. Among those eligible for ART, a high proportion initiated ART and achieved viral suppression, indicating high adherence and reduced infectiousness.
Authors: Juliet N Sekandi; Hassard Sempeera; Justin List; Micheal Angel Mugerwa; Stephen Asiimwe; Xiaoping Yin; Christopher C Whalen Journal: BMC Public Health Date: 2011-09-26 Impact factor: 3.295
Authors: Reuben Granich; James G Kahn; Rod Bennett; Charles B Holmes; Navneet Garg; Celicia Serenata; Miriam Lewis Sabin; Carla Makhlouf-Obermeyer; Christina De Filippo Mack; Phoebe Williams; Louisa Jones; Caoimhe Smyth; Kerry A Kutch; Lo Ying-Ru; Marco Vitoria; Yves Souteyrand; Siobhan Crowley; Eline L Korenromp; Brian G Williams Journal: PLoS One Date: 2012-02-13 Impact factor: 3.240
Authors: Ramzi A Alsallaq; Jared M Baeten; Connie L Celum; James P Hughes; Laith J Abu-Raddad; Ruanne V Barnabas; Timothy B Hallett Journal: PLoS One Date: 2013-01-23 Impact factor: 3.240
Authors: Wei Chang; Gabriel Chamie; Daniel Mwai; Tamara D Clark; Harsha Thirumurthy; Edwin D Charlebois; Maya Petersen; Jane Kabami; Emmanuel Ssemmondo; Kevin Kadede; Dalsone Kwarisiima; Norton Sang; Elizabeth A Bukusi; Craig R Cohen; Moses Kamya; Diane V Havlir; James G Kahn Journal: J Acquir Immune Defic Syndr Date: 2016-11-01 Impact factor: 3.731
Authors: David N Burns; Victor DeGruttola; Christopher D Pilcher; Mirjam Kretzschmar; Christopher M Gordon; Elizabeth H Flanagan; Christopher Duncombe; Myron S Cohen Journal: AIDS Res Hum Retroviruses Date: 2014-02-11 Impact factor: 2.205
Authors: Ruanne V Barnabas; Heidi van Rooyen; Elioda Tumwesigye; Justin Brantley; Jared M Baeten; Alastair van Heerden; Bosco Turyamureeba; Philip Joseph; Meighan Krows; Katherine K Thomas; Torin T Schaafsma; James P Hughes; Connie Celum Journal: Lancet HIV Date: 2016-03-10 Impact factor: 12.767